Formulation and evaluation of silver nanoparticles as antibacterial and antifungal agents with a minimal cytotoxic effect

International Journal of Drug Delivery

Volumn 1, Issue 2, 2011, Pages 293-304

  Salem, H F ^a   Eid, K A M ^b   Sharaf, M A ^c  

^a Beni Suef University   (Egypt)

^b Helwan University   (Egypt)

^c The American University in Cairo   (Egypt)

Author keywords

Antibacterial; Antifungal; Cytotoxicity; Micro plate assay; Release kinetics; Silver nanoparticles

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; SILVER NANOPARTICLE;

ARTICLE; ASPERGILLUS; COLLOID; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; KINETICS; NONHUMAN; PARTICLE SIZE; PENICILLIUM; PSEUDOMONAS PNEUMONIA; SALMONELLA; STAPHYLOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; BACTERIAL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY TEST; DRUG DETERMINATION; DRUG EFFECT; DRUG FORMULATION; DRUG SOLUBILITY; NANOFABRICATION; PH MEASUREMENT; PSEUDOMONAS AERUGINOSA; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 79958157169     PISSN: None     EISSN: 09750215     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Alivisatos AP, Semiconductor Clusters, Nanocrystals and Quantum Dots. Science 1996;271:933-937.
2. Elechiguerra JL, Burt J, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. Interaction of Silver Nanoparticles with HIV-1. J. Nanobiotechnol. 2005;3:1-10.
3. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO, Biomed. Mater J. Res. 2003;52:662.
4. Petica A, et al. Colloidal silver solutions with antimicrobial properties', Materials Science and Engineering: B. 2008;152(1-3):22-27.
5. Israelachvili JN, Intermolecular Surface Forces, 2nd ed, Academic Press, San Diego, 1992.
6. Fendler JH, Korean J. Colloidal Nanoparticles and Nanoparticulate Films Grown at the Air-Water Interface in Reactions and Synthesis in Surfactant Systems Chem. Eng. 2001;18(1):1-13.
7. Henglein A, Meisel D. Spectrophotometric Observations of the Adsorption of Organosulfur Compounds on Colloidal Silver Nanoparticles J. Phys. Chem. B 1998;102: 8364.
8. Kreibig U, Vollmer M. Optical Properties of Metal Clusters. Springer: New York, 1995.
9. El-Sayed MA. Some Interesting Properties of Metals Confined in Time and Nanometer Space of Different Shapes. Acc. Chem. Res. 2001;34:257-264.
10. Frens G. Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions Nature Phys. Sci. 1973;241:20-22.
11. Christian GD, Feldman FJ. Atomic Absorption Spectroscopy Applications in Agriculture, Biology and Medicine, John Wiley & Sons, Inc., 1970.
12. Valcarcel M, Luque de Castro M D, Flow-Injection Analysis principles an applications', Ellis Horwood Ltd., Halsted Press a division of John Wiley & Sons, 1987.
13. Thompson M, Walsh JN. Handbook of Inductively Coupled Plasma Spectrometry', 2nd ed., Blackie & Son Ltd., 1989.
14. Tenover F, et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. Journal of Clinical Microbiology, 1994;32(2):407.
15. 3: formation and characterisation of silver particles. New Journal of Chemistry, 2001. 25(12): 1486-1494.
16. Choi O and Hu Z. Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environmental science & technology, 2008;42(12):4583-4588.
17. Fu J, et al. Construction of antibacterial multilayer films containing nanosilver via layer by layer assembly of heparin and chitosan silver ions complex. Journal of Biomedical Materials Research Part A, 2006;79(3):665-674.
18. International Standard Methods for determination of particle size distribution part 8: photon correlation spectroscopy, International organization for standardization ISO, 13321, 1996.
19. Riddick T. Control of colloid stability through zeta potential: with a closing chapter on its relationship to cardiovascular disease: Published for Zeta-Meter, inc., by Livingston Pub Co., 1968.
20. Margalit R, Okon M, Yerushalmi Y, Avidor E. Bioadhesive Liposomes for Topical Drug Delivery: Molecular and Cellular Studies. J. Controlled Release 1992;19:275-287.
21. Yerushalmi N, Margalit R. Physicochemical Evaluation of a Stability-Driven Approach to Drug Entrapment in Regular and in Surface-Modified Liposomes. Biochem. Biophys. Acta.1994; 1189:13-20.
22. Margalit R, Alon R, Linenberg M, Rubin I, Roseman TJ, Wood RW. Liposomal Drug Delivery: Thermodynamic and Chemical Kinetic Considerations J. Controlled Release 1991;17:285-296.
23. Margalit R, Okon M, Yerushalmi N and Avidor E. Liposome-encapsulated silver sulfadiazine (SSD) for the topical treatment of infected burns: Thermodynamics of drug encapsulation and kinetics of drug release J. Controlled Release 1992;19:275.
24. Yerushalmi N and Margalit R. Physicochemical Evaluation of a Stability-Driven Approach to Drug Entrapment in Regular and in Surface-Modified Liposomes, Biochem. Biophys. Acta 1994;1189:13.
25. Margalit R, Alon R, Linenberg M, Rubin RJ Roseman RW, Wood J. Liposomal drug delivery: thermodynamic and chemical kinetic considerations, J. Controlled Release 1991;17:285.
26. Kim J, et al, Antimicrobial effects of silver nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine, 2007;3(1):95-101.
27. Sondi I and Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. Journal of Colloid and Interface Science, 2004;275(1):177-182.
28. Gill S, et al, Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. Journal of bacteriology, 2005;187(7):2426.
29. Choi O, Hu Z. Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environmental science & technology, 2008;42(12):4583-4588.
30. Singh N, et al, NanoGenotoxicology: The DNA damaging potential of engineered nanomaterials. Biomaterials, 2009;30(23-24):3891-3914.
31. Samberg M, Orndorff P, Monteiro-Riviere N. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology, (0):1-10.
32. Pal S, Tak Y, Song J. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Applied and environmental microbiology, 2007;73(6):1712.
33. Li X, et al, Effects of molecular weight and concentration of chitosan on antifungal activity against Aspergillus Niger. Iran Polym J. 2008;17:843-852.
34. Ma Y, Zhou T, and Zhao C. Preparation of chitosan-nylon-6 blended membranes containing silver ions as antibacterial materials. Carbohydrate research, 2008;343(2):230-237.
35. Berger T, et al, Antifungal properties of electrically generated metallic ions. Antimicrobial Agents and Chemotherapy, 1976;10(5):856.
36. Chen Y, et al, Anti-bacterial and cytotoxic properties of plasma sprayed silver-containing HA coatings. Journal of Materials Science: Materials in Medicine, 2008;19(12):3603-3609.
37. Sung W, Park K, Lee D. Poster Session: Chemical Genomics and Drug Discovery; Antifungal effects and its mode of action of silver nanoparticles against human pathogenic fungi. 2007;2007:355.
38. Nierman W, et al, Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature, 2005;438(7071):1151-1156.
39. Suh J, Wirtz D, Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. Proceedings of the National Academy of Sciences of the United States of America, 2003;100(7):3878.